Intranasal epinephrine formulations and methods for the treatment of disease Grant US-11918655-B2 United States of America 05 Mar 2024
Materials and methods for inducing therapeutic hypothermia in a mammalian subject Grant US-11918659-B2 United States of America 05 Mar 2024
Dry powder formulations of epinephrine and associated methods Grant US-11872308-B2 United States of America 16 Jan 2024
Administration of benzodiazepine compositions Grant US-11793786-B2 United States of America 24 Oct 2023
GRAPHENE-BASED DRUG DELIVERY DEVICE FOR MUCOSAL AND TRANSMUCOSAL ADMINISTRATION Application WO-2023174910-A1 World Intellectual Property Organisation (WIPO) 21 Sep 2023
Intranasal epinephrine formulations and methods for the treatment of disease Grant US-11744895-B2 United States of America 05 Sep 2023
Intranasal epinephrine formulations and methods for the treatment of disease Grant US-11717571-B2 United States of America 08 Aug 2023
NASAL VACCINE-SPRAYING FORMULATION FOR SIMULTANEOUSLY TARGETING NASAL MUCOSA AND… Application WO-2023100984-A1 World Intellectual Property Organisation (WIPO) 08 Jun 2023
Dry powder formulations of epinephrine and associated methods Grant US-11617716-B2 United States of America 04 Apr 2023
Administration of benzodiazepine compositions Grant US-11241414-B2 United States of America 08 Feb 2022
Intranasal epinephrine formulations and methods for the treatment of disease Grant US-11191838-B2 United States of America 07 Dec 2021
Oligopyrroles as antagonists of islet amyloid polypeptide oligomerization Grant US-11124479-B2 United States of America 21 Sep 2021
Alpha-helix mimetics as modulators of Abeta self-assembly Grant US-10723716-B2 United States of America 28 Jul 2020
Intranasal epinephrine formulations and methods for the treatment of disease Grant US-10682414-B2 United States of America 16 Jun 2020
Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor… Grant US-10500197-B2 United States of America 10 Dec 2019
Dosing regimens for fast onset of antidepressant effect Grant US-10258617-B2 United States of America 16 Apr 2019
Dosing regimens for fast onset of antidepressant effect Grant US-9913839-B2 United States of America 13 Mar 2018
Dosing regimens for fast onset of antidepressant effect Grant US-9820984-B1 United States of America 21 Nov 2017
Pharmaceutical composition including alkyl glycoside and an anti-seizure agent Grant US-9642913-B2 United States of America 09 May 2017
Therapeutic compositions for intranasal administration of zolpidem Application US-8916583-B2 United States of America 23 Dec 2014
Absorption enhancers for intranasal interferon administration Grant US-8551468-B2 United States of America 08 Oct 2013
Pharmaceutical formulations for intranasal administration of protein comprising a… Grant US-8481070-B2 United States of America 09 Jul 2013
High molecular weight, low methoxyl pectins, and their production and uses Grant US-7691986-B2 United States of America 06 Apr 2010
Pharmaceutical formulations for intranasal administration of protein comprising a… Grant US-7662403-B2 United States of America 16 Feb 2010
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides Grant US-7494669-B2 United States of America 24 Feb 2009
TRANSMUCOSAL DELIVERY OF PEPTIDE DERIVATIVES Application WO-2006135930-A3 World Intellectual Property Organisation (WIPO) 31 May 2007
TRANSMUCOSAL DELIVERY OF PEPTIDE DERIVATIVES Application WO-2006135930-A2 World Intellectual Property Organisation (WIPO) 21 Dec 2006
PEPTIDE YY FORMULATIONS HAVING INCREASED STABILITY AND RESISTANCE TO MICROBIAL AGENTS Application WO-2006007412-A3 World Intellectual Property Organisation (WIPO) 13 Apr 2006
PEPTIDE YY FORMULATIONS HAVING INCREASED STABILITY AND RESISTANCE TO MICROBIAL AGENTS Application WO-2006007412-A2 World Intellectual Property Organisation (WIPO) 19 Jan 2006
INTRANASAL FORMULATIONS OF INTERFERON BETA FREE OF STABILIZERS THAT ARE PROTEINS OR… Application WO-2005120551-A1 World Intellectual Property Organisation (WIPO) 22 Dec 2005
PHARMACEUTICAL FORMULATIONS FOR INTRANASAL ADMINISTRATION OF PROTEIN COMPRISING A… Application WO-2005004838-A1 World Intellectual Property Organisation (WIPO) 20 Jan 2005